These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 30105031)
41. Natural killer cells and unconventional T cells in COVID-19. Björkström NK; Ponzetta A Curr Opin Virol; 2021 Aug; 49():176-182. PubMed ID: 34217135 [TBL] [Abstract][Full Text] [Related]
42. Mucosal-associated invariant T cells are depleted and functionally altered in patients with common variable immunodeficiency. Arduini S; Dunne J; Conlon N; Feighery C; Doherty DG Clin Immunol; 2017 Mar; 176():23-30. PubMed ID: 28011187 [TBL] [Abstract][Full Text] [Related]
43. Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis. Hayashi E; Chiba A; Tada K; Haga K; Kitagaichi M; Nakajima S; Kusaoi M; Sekiya F; Ogasawara M; Yamaji K; Tamura N; Takasaki Y; Miyake S J Rheumatol; 2016 Sep; 43(9):1695-703. PubMed ID: 27370879 [TBL] [Abstract][Full Text] [Related]
44. Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL-17. Sobkowiak MJ; Davanian H; Heymann R; Gibbs A; Emgård J; Dias J; Aleman S; Krüger-Weiner C; Moll M; Tjernlund A; Leeansyah E; Sällberg Chen M; Sandberg JK Eur J Immunol; 2019 Jan; 49(1):133-143. PubMed ID: 30372518 [TBL] [Abstract][Full Text] [Related]
45. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390 [TBL] [Abstract][Full Text] [Related]
46. Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer. Shey MS; Balfour A; Wilkinson KA; Meintjes G Innate Immun; 2018 May; 24(4):192-202. PubMed ID: 29631470 [TBL] [Abstract][Full Text] [Related]
47. T cells and NKT cells in the pathogenesis of asthma. Meyer EH; DeKruyff RH; Umetsu DT Annu Rev Med; 2008; 59():281-92. PubMed ID: 17937589 [TBL] [Abstract][Full Text] [Related]
48. Reduced IL-12 level correlates with decreased IFN-gamma secreting T cells but not natural killer cell activity in asthmatic children. Chou CC; Huang MS; Hsieh KH; Chiang BL Ann Allergy Asthma Immunol; 1999 May; 82(5):479-84. PubMed ID: 10353580 [TBL] [Abstract][Full Text] [Related]
49. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation. Kawaguchi K; Umeda K; Hiejima E; Iwai A; Mikami M; Nodomi S; Saida S; Kato I; Hiramatsu H; Yasumi T; Nishikomori R; Kondo T; Takaori-Kondo A; Heike T; Adachi S Int J Hematol; 2018 Jul; 108(1):66-75. PubMed ID: 29582333 [TBL] [Abstract][Full Text] [Related]
50. Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis. Braudeau C; Amouriaux K; Néel A; Herbreteau G; Salabert N; Rimbert M; Martin JC; Hémont C; Hamidou M; Josien R J Autoimmun; 2016 Jun; 70():73-9. PubMed ID: 27102145 [TBL] [Abstract][Full Text] [Related]
51. STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model. Gavino AC; Nahmod K; Bharadwaj U; Makedonas G; Tweardy DJ Allergy; 2016 Dec; 71(12):1684-1692. PubMed ID: 27225906 [TBL] [Abstract][Full Text] [Related]
52. CD1d- and MR1-restricted invariant T cells: of mice and men. Treiner E; Lantz O Curr Opin Immunol; 2006 Oct; 18(5):519-26. PubMed ID: 16870416 [TBL] [Abstract][Full Text] [Related]
54. Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation. Vultaggio A; Nencini F; Pratesi S; Petroni G; Romagnani S; Maggi E Allergy; 2012 Oct; 67(10):1223-32. PubMed ID: 22882449 [TBL] [Abstract][Full Text] [Related]
55. Mucosal-associated invariant T cells in autoimmune and immune-mediated diseases. Rouxel O; Lehuen A Immunol Cell Biol; 2018 Jul; 96(6):618-629. PubMed ID: 29405379 [TBL] [Abstract][Full Text] [Related]
56. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492 [TBL] [Abstract][Full Text] [Related]
57. Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes. Hussain S; Wagner M; Ly D; Delovitch TL Immunol Res; 2005; 31(3):177-88. PubMed ID: 15888910 [TBL] [Abstract][Full Text] [Related]
58. Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity. Dias J; Sobkowiak MJ; Sandberg JK; Leeansyah E J Leukoc Biol; 2016 Jul; 100(1):233-40. PubMed ID: 27034405 [TBL] [Abstract][Full Text] [Related]
59. New insights into the role of cytokines in asthma. Renauld JC J Clin Pathol; 2001 Aug; 54(8):577-89. PubMed ID: 11477111 [TBL] [Abstract][Full Text] [Related]
60. Mucosal-associated invariant T cells: new players in CF lung disease? Anil N Inflamm Res; 2019 Aug; 68(8):633-638. PubMed ID: 31201438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]